Literature DB >> 16954612

Tetrakis[2-(2-pyridyl)pyridinium] tetra-mu3-iodo-hexa-mu2-iodo-dodecaiodohexabismuthate and bis[tris(2,2'-bipyridine)ruthenium(II)] di-mu4-iodo-octa-mu2-iodo-dodecaiodohexabismuthate.

Andrea M Goforth1, Meredith A Tershansy, Mark D Smith, LeRoy Peterson, Hans-Conrad zur Loye.   

Abstract

Crystals of the title compounds were grown solvothermally in an ethanol-water solvent mixture using ruthenium triiodide, 2,2'-bipyridine and bismuth triiodide as starting materials. Tetrakis[2-(2-pyridyl)pyridinium] tetra-mu3-iodo-hexa-mu2-iodo-dodecaiodohexabismuthate, (C10H9N2)4[Bi6I22], crystallizes in the triclinic space group P-1 and is the major reaction product. The asymmetric unit of this compound consists of half a centrosymmetric [Bi6I22]4- anion and two independent 2,2'-bipyridinium cations. The minor product of the reaction is bis[tris(2,2'-bipyridine)ruthenium(II)] di-mu4-iodo-octa-mu2-iodo-dodecaiodohexabismuthate, [Ru(C10H8N2)3]2[Bi6I22], which also crystallizes in the triclinic space group P-1. For this compound, the asymmetric unit consists of one full [Ru(2,2'-bipyridine)3]2+ cation and half a centrosymmetric [Bi6I22]4- anion. Although both compounds contain a centrosymmetric [Bi6I22]4- anion, the polyhedral arrangement of the distorted BiI6 octahedra in the two compounds is quite different, and the anion of the latter compound has not previously been observed in iodobismuthate chemistry.

Entities:  

Year:  2006        PMID: 16954612     DOI: 10.1107/S0108270106025972

Source DB:  PubMed          Journal:  Acta Crystallogr C        ISSN: 0108-2701            Impact factor:   1.172


  2 in total

1.  Diaqua-bis(9-oxo-4,5-diaza-fluoren-3-olato-κN,O)cadmium(II).

Authors:  Ya-Hui Zhao; Xing Yuan; Wei-Chao Qin; Lian-Xi Sheng; Yun-Zheng Ding
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2008-01-04

2.  Multiple Roles of 1,4-Diazabicyclo[2.2.2]octane in the Solvothermal Synthesis of Iodobismuthates.

Authors:  Yunhe Cai; Ann M Chippindale; Richard J Curry; Paz Vaqueiro
Journal:  Inorg Chem       Date:  2021-03-22       Impact factor: 5.165

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.